Insperity (NSP) traded down -0.92 % during a 24 hours period ending at 10:10 PM Central Europe on Tuesday 27th. One Insperity stock can currently be bought for about USD 51.79 on popular exchanges. Current supply of Insperity stocks is 38.2 mn. Insperity has a current market capitalization of USD 2.1 bn and approximately USD 20.9 mn worth of Insperity was traded on exchanges in the last 24 hours. Since last month end, Insperity has traded 14.99 % up. Simple moving average of last 200 days is at USD 39.42. The highest price of past 52 weeks was recorded at USD 55.9 on 07/29/2026. 52 weeks low was at USD 18.57 on 03/11/2026.
Here is how related stocks have performed in the past 24 hours:
Payoneer Global (PAYO) traded flat 0 % and now trades at USD 7.13. Current market capitalisation for Payoneer Global is USD 2.4 bn. Payoneer Global has a current price to earnings ratio of 50.75.
Vertex (VERX) traded down -1.43 % and now trades at USD 14.8. Current market capitalisation for Vertex is USD 2.5 bn. Vertex has a current price to earnings ratio of 696.36. Vertex Inc. announced the launch of Vertex Sōl, a connected, AI‑powered solution designed to unify tax and compliance processes across the entire transaction lifecycle. The platform links tax decisions, workflows, evidence, and AI guidance from determination through electronic invoicing, reporting, and audit defense, creating a continuous, traceable record. Vertex emphasizes that the system offers full visibility into AI operations while allowing tax teams to review, override, or reverse actions at various levels of automation. The introduction follows a survey indicating that a majority of decision makers seek complete transparency and control over AI‑generated compliance decisions. Vertex positions Sōl as an extension of its existing Decision‑to‑Defense offerings, trusted by more than sixty percent of Fortune 500 firms, and aims to enhance governance, explainability, and defensibility in indirect tax and compliance activities.
Innospec (IOSP) traded up 0.55 % and now trades at USD 99.92. Current market capitalisation for Innospec is USD 2.4 bn. Innospec has a current price to earnings ratio of 20.1.
Clover Health Investments (CLOV) traded down -0.87 % and now trades at USD 4.63. Current market capitalisation for Clover Health Investments is USD 2.4 bn. Clover Health Investments, Corp. announced that its Interim Chief Financial Officer will speak at the upcoming UBS Global Healthcare Conference on November 9, 2026. The presentation will be streamed live and recorded for later viewing on the company’s investor relations website. Clover Health, a physician‑enablement technology firm, focuses on expanding access to high‑quality healthcare for Medicare beneficiaries, particularly seniors who historically face limited options. Its strategy relies on a software platform that aggregates patient data to support clinical decision‑making and improve outcomes, especially through early detection and management of chronic diseases. The company offers Medicare Advantage plans and extends its data‑driven platform to external providers via a subsidiary, aiming to enhance patient outcomes and reduce costs nationwide.
Transmedics (TMDX) traded down -0.16 % and now trades at USD 69.73. Current market capitalisation for Transmedics is USD 2.4 bn. Current price/earnings ratio for Transmedics is 17.87.
About Insperity
Insperity, Inc. is a U.S.-based company that specializes in providing human resources and business optimization services. The company offers various services such as recruitment, employment screening, retirement plans, business insurance, and technology support. Additionally, Insperity provides solutions for performance and expense management, time and attendance, and organizational planning through software offerings. You can find more information about their services and offerings on their website at www.insperity.com . The company is listed on the New York Stock Exchange and had its initial public offering (IPO) on January 28, 1997.